Oliver Wyman, a management consulting firm and part of Marsh McLennan, has announced an agreement to acquire Validate Health, a healthcare analytics company that supports healthcare providers and Accountable Care Organisations (ACOs) in improving cost management, risk assessment, and operational performance.
Financial details of the transaction, which is expected to close in summer 2025, have not been disclosed.
Following the acquisition, Validate Health will become part of Oliver Wyman Actuarial, a specialised division that delivers actuarial expertise to insurers, investors, healthcare systems, corporations, and other clients.
The addition of Validate Health enhances Oliver Wyman’s capabilities with advanced analytics and technology tools designed to help clients expand market reach, improve profitability, fine-tune programmes, manage financial risk, and attract investment—all while supporting improved patient outcomes.
“Healthcare is a complex and critical industry featuring a unique set of challenges, and it is undergoing a seismic shift,” added David Weinsier, Partner, Global Life and Health Leader for Oliver Wyman Actuarial.
<!–
–>
“This acquisition allows us to not only meet that moment but lead it. By combining our deep actuarial and policy expertise with Validate Health’s data-driven solutions, we are at the forefront of building an analytics platform that helps clients improve healthcare delivery and drive efficiency.”
Andrew Webster, Validate Health Co-Founder, said: “This is a milestone moment for us. From the start, our mission has been to make healthcare better through data. Joining forces with Oliver Wyman gives us the reach, actuarial and insurance expertise, and complementary skillsets to supercharge that mission. Our clients – and their patients – stand to gain the most.”
The post Oliver Wyman to acquire Validate Health, expanding healthcare analytics capabilities appeared first on ReinsuranceNe.ws.
